---
layout: minimal-medicine
nav_exclude: true
title: Ruxolitinib
---

# Ruxolitinib

**Generic Name:** Ruxolitinib

**Usage:**

Ruxolitinib is used to treat:

* **Intermediate- or high-risk myelofibrosis (MF):** A type of bone marrow cancer.  It helps to reduce spleen size, alleviate symptoms like fatigue, night sweats, and abdominal fullness, and improve overall survival in some patients.
* **Polycythemia vera (PV):** Another type of bone marrow cancer. It's used to control symptoms and reduce the risk of complications.


**Side Effects:**

Ruxolitinib can cause a variety of side effects, some common and some rare.  The frequency and severity vary between individuals.  Common side effects include:

* **Thrombocytopenia (low platelet count):** This can increase the risk of bleeding.
* **Anemia (low red blood cell count):** Leading to fatigue and weakness.
* **Neutropenia (low neutrophil count):**  Increasing the risk of infection.
* **Nausea and vomiting:** Digestive upset.
* **Diarrhea:** Gastrointestinal issues.
* **Fatigue:** Feeling tired and weak.
* **Headache:** Pain in the head.
* **Skin rash:**  Irritation or allergic reactions on the skin.
* **Increased risk of infections:** Due to the decreased white blood cell count.
* **Elevated liver enzymes:** Indicating potential liver damage.


Serious, though less common, side effects can include:

* **Severe bleeding:** Due to low platelets.
* **Serious infections:**  Due to low white blood cell counts.
* **Pulmonary embolism (blood clot in the lungs):** A life-threatening condition.
* **Hepatotoxicity (liver damage):**  Liver function should be monitored.
* **Herpes zoster (shingles):** Reactivation of the chickenpox virus.


**This is not an exhaustive list, and you should consult your doctor or pharmacist for a complete list of potential side effects.**


**How it Works:**

Ruxolitinib is a Janus kinase (JAK) inhibitor.  JAK enzymes are involved in the signaling pathways that control cell growth and development.  In myelofibrosis and polycythemia vera, these pathways are abnormally activated, leading to excessive production of blood cells and other symptoms.  Ruxolitinib works by blocking the activity of JAK enzymes, thereby reducing the overproduction of blood cells and mitigating the associated symptoms.


**FAQs:**

* **Q: How is ruxolitinib administered?** A: Ruxolitinib is usually taken orally as a tablet, twice daily.
* **Q: How long will I need to take ruxolitinib?** A: The duration of treatment varies depending on your individual response and the disease being treated. Your doctor will determine the appropriate treatment duration.
* **Q: What are the monitoring requirements while on ruxolitinib?** A: Regular blood tests are needed to monitor your blood cell counts (complete blood count or CBC), liver function tests, and overall health.
* **Q: Can I take other medications with ruxolitinib?** A:  It's crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking. Certain drug interactions are possible.
* **Q: What are the potential long-term effects of ruxolitinib?** A: Long-term effects are still being studied, but regular monitoring is crucial to detect and manage potential complications.
* **Q: What should I do if I experience side effects?** A: Contact your doctor immediately if you experience any concerning side effects, particularly severe ones such as bleeding or infection.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized advice based on your individual medical history and condition.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.